Document is current

Article History

Received: 19 April 2024

Accepted: 24 October 2024

First Online: 5 November 2024

Declarations

:

: EL’s employer, Griffith University, has received on her behalf: an investigator-initiated grant-in-aid from Eloquest Healthcare; and a scholarship (conference attendance) supported by Angiodynamics. EL is supported by a Royal Brisbane and Women’s Hospital Post-Graduate Scholarship. CMR’s employers (The University of Queensland or Griffith University) employer has received, on her behalf: investigator-initiated research or educational grants from 3M, BD-Bard, Cardinal Health, Eloquest Healthcare; and consultancy payments for educational lectures/expert advice from 3M, BD-Bard and ITL Biomedical. NM’s former employer (Griffith University) has received on her behalf: investigator-initiated research grants and unrestricted educational grants from BD-Bard, Eloquest Healthcare and Cardinal Health; and a consultancy payment from BD-Bard. AU’s current (University of Queensland) and/or former employer (Griffith University), have received on her behalf: investigator-initiated grants from 3M, BD-Bard, and Cardinal Health; and a speaker fee from 3M. VC has received grant funding from the Agency for Healthcare Research and Quality, Blue Cross/Blue Shield of Michigan, and the National Institute for Health. AC: AC’s current (Griffith University) and former employers (University of Queensland) have received, on her behalf, investigator-initiated research grant from Cardinal Health and Eloquest Healthcare (unrelated to the current project). NG: NG’s employer has, on her behalf received educational funding and honoraria from ICU Medical and Hospira. JB’s employer, Griffith University, has received on his behalf: an investigator-initiated grant-in-aid from BD-Bard, NeoNav, 3M, Edwards Life Sciences and Abbott. MF, RP, DT and BS report no financial or non-financial interests to disclose.